TaiMed Biologics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 8.1%.

Top 22 shareholders own 29.91% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.6%	National Development Fund, Executive Yuan	39,932,000	NT$3.5b	0%	0.22%
6.64%	Huei Hong Investment Co., Ltd.	18,115,895	NT$1.6b	0%	no data
2.89%	The Vanguard Group, Inc.	7,888,984	NT$687.9m	0%	no data
1.2%	Nian Yuan Zhang	3,282,652	NT$286.2m	16.8%	no data
1.15%	BlackRock, Inc.	3,152,021	NT$274.9m	0.13%	no data
1.05%	Renying Industrial Co., Ltd.	2,874,076	NT$250.6m	0%	no data
0.86%	Norges Bank Investment Management	2,339,555	NT$204.0m	0%	no data
0.4%	Capital Investment Trust Corporation	1,100,729	NT$96.0m	0%	0.05%
0.29%	Mega International Investment Trust Co., Ltd.	782,378	NT$68.2m	0%	0.15%
0.24%	Chang Chuen Investment Co., Ltd.	668,071	NT$58.3m	6.32%	no data
0.17%	Chin-Ming Chang	452,254	NT$39.4m	0%	no data
0.14%	State Street Global Advisors, Inc.	382,306	NT$33.3m	-3.53%	no data
0.12%	Chi-Chuan Chen	337,043	NT$29.4m	0%	no data
0.055%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	150,000	NT$13.1m	0%	no data
0.036%	Geode Capital Management, LLC	99,603	NT$8.7m	34.9%	no data
0.011%	Storebrand Fonder AB,	31,000	NT$2.7m	0%	no data
0.0081%	Eaton Vance Management	22,000	NT$1.9m	0%	no data
0.0053%	HSBC Global Asset Management (UK) Limited	14,459	NT$1.3m	0%	no data
0.0052%	Northern Trust Global Investments	14,262	NT$1.2m	0%	no data
0.0015%	Tien-Chieh Lee	4,000	NT$350.0k	0%	no data
0.0008%	Eurizon Capital S.A.	2,190	NT$190.5k	0%	no data
0.0006%	BMO Asset Management Corp.	1,651	NT$142.8k	0%	no data